ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Income Statement
USA - NASDAQ:ESLA - US2975841048 - Common Stock
2.55 USD
+0.09 (+3.66%)
| TTM (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 12.08M | 7.31M | 11.11M | 1.69M | 250.00K | |||
| Research and Development | 8.93M | 4.11M | 10.45M | 1.39M | N/A | |||
| Selling, General, and Administrative Expenses | 3.15M | 3.20M | 663.20K | 296.30K | 70.00K | |||
| Operating Income | -12.08M | -7.31M | -11.11M | -1.69M | -250.00K | |||
| Interest Income/Expense | N/A | N/A | 650.00K | 650.00K | 0.00 | |||
| Income Before Taxes | -12.08M | -7.31M | -11.11M | -1.69M | -250.00K | |||
| Income Tax | 1.00K | 1.60K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -12.08M | -7.31M | -11.11M | -1.69M | -250.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.33 | -0.20 | -0.32 | -0.05 | -0.21 | |||
| Statistics | ||||||||
All data in USD